In the past many of us have wished there was a list of FDA-approved stem cell therapies. Patients and fellow scientists often asked me, but I couldn’t find a list.
As a result, I made a comprehensive list, which is the focus of today’s post. I’ve updated the list now in 2024 with the great news that Casgevy and Lyfgenia, gene therapies for sickle cell, are now approved as of late 2023.
What is in this article?
FDA and cell therapies
Other than what I mentioned above, there was nothing else approved that was an actual stem cell therapy. There were, however, cellular therapies approved even if not related to stem cells. In a way these fit into the broader category of regenerative medicine.
Note that you can watch me discuss this post in a new YouTube Video below.
List of diseases treated by stem cells & FDA approved
What about today in 2022? Before we get to the approved products, I made a short list of the diseases treated by stem cells.
Note that only very specific products matched with specific forms of these diseases have the FDA OK. For instance just because damaged cartilage is on the list doesn’t mean anything goes. There’s no approval to treat it with fat stem cells, bone marrow, umbilical cord cells or exosomes.
- Mantle Cell Lymphoma
- Large B-Cell Lymphoma
- B-Cell ALL
- Prostate Cancer
- Some other kinds of cancer
- Facial wrinkles (specific type)
- Receding gums
- Damaged cartilage
- Leber congenital amaurosis (a retinal disorder)
- SMA or spinal muscular atrophy
The list of diseases has been growing. What about the products?
FDA Approved Stem Cell Therapies, key context
We need to turn to the FDA itself for the clearest answer on where things stand now.
Too often stem cell clinics claim that what they offer is “FDA approved”. In actuality at best what some of them sell is not FDA approved, but rather technically compliant with the rules for 361 products. What this means in English is that the products are not regulated as drugs.
So what does the FDA have to say about what they have approved?
In mid-2020, they issued an advisory, “Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes.” In it they wrote:
“Stem cell products are regulated by FDA, and, generally, all stem cell products require FDA approval. Currently, the only stem cell products that are FDA-approved for use in the United States consist of blood-forming stem cells (also known as hematopoietic progenitor cells) that are derived from umbilical cord blood. These products are approved for use in patients with disorders that affect the production of blood (i.e., the “hematopoietic” system) but they are not approved for other uses.”
This fits with the general boilerplate some of us in the stem cell field have used, as noted earlier.
Note that, of course, the US and the FDA are not the only ones in this arena. The Alliance for Regenerative Medicine has what we might call an international list of cleared cell and gene therapies here. They are a great organization.
Cell and gene therapies
The good news today is that the agency has an actual list that is publicly available. Even better news is that there are more approved cell therapies than last time I tried to tackle this topic.
An interesting side note is that the agency for several years now has been combining together cell and gene therapies into one category. This is also reflected in their Regenerative Medicine Advanced Therapy (RMAT) designation program, which contains both types. RMATs still have to go through the trial approval process but get special consideration. You can see a help infographic below that my intern Mina made of the clinical trial approval process.
The formal FDA list of approved drugs made from stem cells is called, appropriately enough, “Approved Cellular and Gene Therapy Products.”
The current list is up to date as of September 1, 2022. I’m going to update this post as the agency updates their list. It’s interesting to speculate on how different this list might be in as short as 5 years given the exciting clinical trials that are ongoing now. In 10 years I predict it’s going to be a much longer list.
List of FDA approved cell and gene therapies as of late 2023
- ABECMA (idecabtagene vicleucel) for refractory myeloma, Celgene Corporation.
- ADSTILADRIN for unresponsive bladder cancer, Ferring Pharmaceuticals
- ALLOCORD (Cord Blood), SSM Cardinal Glennon Children’s. “For use in unrelated donor hematopoietic progenitor cell transplantation.”
- BREYANZI CAR-T-cell therapy for adults with relapsed or refractory large B-cell lymphoma, Juno Therapeutics.
- CARVYKTI for refractory myeloma, Janssen
- CASGEVY, Vertex.
- CLEVECORD, Cleveland Cord Blood Center. Similar to ALLOCORD.
- Ducord, Cord Blood, Duke Med School, Similar to ALLOCORD.
- ELEVIDYS for DMD, Sarepta Therapeutics
- GINTUIT for receding gums, Organogenesis.
- HEMACORD (cord blood), New York Blood Center. This and the four that follow are similar to ALLOCORD.
- Cord Blood, Clinimmune Labs.
- Cord Blood – MD Anderson.
- Cord Blood – LifeSouth.
- Cord Blood – Bloodworks
- IMLYGIC An oncolytic gene therapy product for treatment of melanoma, BioVex.
- KYMRIAH CAR-T cell therapy for B-cell acute lymphoblastic leukemia (B-Cell ALL), Novartis.
- LANTIDRA for Type 1 diabetes, CellTrans Inc.
- LAVIV Treatment of deep wrinkles on the sides of our noses, Fibrocell Technologies.
- LUXTURNA for Leber congenital amaurosis, Spark Therapeutics.
- LYFGENIA, bluebird bio.
- MACI for damaged cartilage, Vericel.
- OMISIRGE for blood cancers, Gamida Cell.
- PROVENGE (sipuleucel-T) for prostate cancer, Dendreon.
- RETHYMIC for athymia, Enzyvant Therapeutics.
- ROCTAVIAN for severe hemophilia A, BioMarin Pharmaceutical.
- SKYSONA for CALD, bluebird bio.
- STRATAGRAFT for burns, Stratatech.
- TECARTUS, CAR-T therapy for treatment of adults with relapsed/refractory mantle cell lymphoma, Kite Pharma.
- YESCARTA CAR-T for large B-cell lymphoma that hasn’t responded to other therapy, Kite Pharma.
- ZOLGENSMA (Nusinersen), AveXis.
- ZYNTEGLO for ß-thalassemia, bluebird bio.
List of FDA approved stem cell clinics
What about list of FDA approved stem cell clinics?
Such a list doesn’t exist.
The reason is because no clinics have FDA approval. While some clinics sell stem cells that don’t need formal FDA drug approval, most need that approval and yet don’t have it.
- Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes, July 22, 2022, FDA advisory
- FDA, list of “Approved Cellular and Gene Therapy Products.” Current as of November 2023.